首页>
外国专利>
VACCINE CAPABLE TO MAKE IMMUNITY IN HOST AGAINST INFECTION CAUSED BY STREPTOCOCCUS GROUP B, METHOD OF PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B AND A METHOD OF ATTENUATION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B
VACCINE CAPABLE TO MAKE IMMUNITY IN HOST AGAINST INFECTION CAUSED BY STREPTOCOCCUS GROUP B, METHOD OF PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B AND A METHOD OF ATTENUATION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B
FIELD: medicine, immunology, vaccines. SUBSTANCE: vaccine has polysaccharide conjugated with protein. Indicated protein and polysaccharide are typical molecules of streptococcus of group B. The used protein is recombinant one S1 and it is encoded by plasmid pJMSI ATCC N 40659. Vaccine induces T-independent immunity against infection caused by streptococcus of group B. Vaccine is able to produce immunity in recipient against infection caused by streptococcus of group B. EFFECT: enhanced effectiveness of vaccine. 8 cl, 6 dwg , 2 tbl
展开▼
机译:领域:医学,免疫学,疫苗。物质:疫苗含有与蛋白质结合的多糖。所示的蛋白质和多糖是B组链球菌的典型分子。所用的蛋白质是重组S1蛋白,由质粒pJMSI ATCC N 40659编码。疫苗可诱导针对B组链球菌感染的T非依赖性免疫。在受体中产生抵抗B组链球菌感染的免疫力。效果:疫苗效力增强。 8厘升,6载重吨,2桶
展开▼